Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Frequently asked questions
What sector does Wave Life Sciences Ltd (WVE) operate in?
Wave Life Sciences Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Wave Life Sciences Ltd (WVE) current stock price?
As of the latest data, Wave Life Sciences Ltd stock price is $3.21, with a previous close of $3.18. Wave Life Sciences Ltd gained $0.03 in the last trading session, representing a 0.94% increase.
What is Wave Life Sciences Ltd (WVE) current market capitalization?
Wave Life Sciences Ltd market cap is approximately 632.52 million.
What is Wave Life Sciences Ltd (WVE) Earnings Per Share (EPS)?
The trailing EPS is -$1.08, and the forward EPS is -$1.16.
What is Wave Life Sciences Ltd (WVE) EBITDA?
Wave Life Sciences Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -71.22 million.
Does Wave Life Sciences Ltd (WVE) pay dividends?
No. Wave Life Sciences Ltd does not pay a dividend.
How did Wave Life Sciences Ltd (WVE) perform in its most recent earnings report?
In the last report (June 30, 2026), Wave Life Sciences Ltd posted an EPS surprise of -9.68% and a revenue surprise of -68.01%.
When is Wave Life Sciences Ltd (WVE) next earnings report?
Wave Life Sciences Ltd is expected to release its next earnings report on September 30, 2026.
What is Wave Life Sciences Ltd (WVE) beta (volatility) score?
Wave Life Sciences Ltd has a beta of -1.303, indicating lower volatility than the overall market.
